The First Affiliated Hospital Of Bengbu Medical University
Clinical trials sponsored by The First Affiliated Hospital Of Bengbu Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Social connection as medicine: a brain-training trial for gaming addiction Results expected Dec 2026 (estimated)
- Can chemotherapy harm the thyroid? a new study investigates Results expected Apr 2027 (estimated)
- Can a pill replace chemo for stomach cancer in the elderly? Results expected Aug 2027 (estimated)
- Can a blood vessel blocker stop Cancer-Related belly fluid? Results expected Sep 2027 (estimated)
- Can adding a Blood-Vessel blocker boost chemotherapy for Triple-Negative breast cancer? Results expected Sep 2027 (estimated)
-
Can a pill replace chemo for stomach cancer in the elderly?
Disease control Recruiting nowThis phase 2 trial tests whether apatinib, taken as a daily pill, can control advanced stomach or gastroesophageal junction cancer in people aged 65 and older who cannot or will not undergo chemotherapy. Participants receive apatinib until the disease worsens or side effects beco…
Phase 2 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can adding a Blood-Vessel blocker boost chemotherapy for Triple-Negative breast cancer?
Disease control Recruiting nowThis Phase 2 trial tests whether adding an antiangiogenic drug to standard chemotherapy helps people with relapsed or metastatic triple-negative breast cancer. Participants receive albumin-bound paclitaxel alone, or combined with either apatinib mesylate (a pill) or bevacizumab (…
Phase 2 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a blood vessel blocker stop Cancer-Related belly fluid?
Disease control Recruiting nowThis trial tests whether the oral drug apatinib can control malignant ascites, a painful buildup of fluid in the belly that can happen with advanced cancer. The study enrolls adults with persistent or symptomatic ascites that has not responded to standard treatments, including di…
Phase 2 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Social connection as medicine: a brain-training trial for gaming addiction
Disease control Recruiting nowThis trial investigates whether a self-help program that enhances social reward can improve cognitive control in people with internet gaming disorder. The program, based on Acceptance and Commitment Therapy, includes social scenario practice and skills training. Researchers will …
Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can chemotherapy harm the thyroid? a new study investigates
Knowledge-focused Recruiting nowThis study follows 400 Chinese women with newly diagnosed breast cancer to see how often thyroid problems occur before and during chemotherapy. Researchers will measure thyroid function and structure at diagnosis and after at least four cycles of anthracycline or taxane-based che…
Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC